Lv7
4380 积分 2020-07-11 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
8天前
已完结
Laryngeal obstruction and obstructive sleep apnea syndrome
10天前
已完结
Voice Disorders in Obstructive Sleep Apnea: Prevalence, Risk Factors, and the Role of CPAP
15天前
已完结
Laryngopharyngeal Reflux and Upper Airway Obstruction Patterns in Nonobese Sleep Apnea Patients
16天前
已完结
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
17天前
已完结
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
1个月前
已关闭
Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study
1个月前
已完结
Association between glucagon-like peptide-1 agonists and risk of diabetic retinopathy: a disproportionality analysis using FDA adverse event reporting system data
1个月前
已完结
Comment on 'Semaglutide and Tirzepatide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World (STEER)'
1个月前
已完结
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
1个月前
已关闭
皖公网安备34019202002308
